Combination therapy with vitamin D3, progesterone, omega-3 fatty acids and glutamine reverses coma and improves clinical outcomes in patients with severe traumatic brain injuries: A case series

Introduction: Traumatic brain injury (TBI) is a major public health problem and a leading cause of death and disability in the United States. Management of patients with TBI has changed very little over the last 20 years. Case Series: A case series of three patients with severe TBIs who were aggressively treated with vitamin D3, progesterone, omega 3­fatty acids, and enteral glutamine for six weeks, termed neuroceutical augmentation for traumatic brain injury (NATBI), with very favorable outcomes. Conclusion: A large clinical study trial using these four supplements (NATBI) together is warranted.

[1]  Y. Ahmed,et al.  Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. , 2012, American journal of surgery.

[2]  D. Stein,et al.  Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury , 2012, Hormones and Behavior.

[3]  M. Yenari,et al.  Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury , 2012, Inflammopharmacology.

[4]  J. Bailes,et al.  Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids. , 2011, Military medicine.

[5]  M. Wald,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006 , 2010 .

[6]  M. Cekic,et al.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease , 2009, Frontiers in Neuroendocrinology.

[7]  D. Stein,et al.  Progesterone with Vitamin D Affords Better Neuroprotection against Excitotoxicity in Cultured Cortical Neurons than Progesterone Alone , 2009, Molecular medicine.

[8]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[9]  De-lin Yang,et al.  Effect of dipeptide of glutamine and alanine on severe traumatic brain injury. , 2007, Chinese journal of traumatology = Zhonghua chuang shang za zhi.

[10]  M. Fukagawa,et al.  [The pleiotropic effects of vitamin D on kidney disease]. , 2007, Clinical calcium.

[11]  Zhen Zheng,et al.  Antiapoptotic and Anti‐inflammatory Mechanisms of Heat‐Shock Protein Protection , 2005, Annals of the New York Academy of Sciences.

[12]  J. Galloway,et al.  Parenteral glutamine increases serum heat shock protein 70 in critically ill patients , 2005, Intensive Care Medicine.

[13]  P. Wischmeyer.  Glutamine and heat shock protein expression. , 2002, Nutrition.

[14]  S. Kelly,et al.  Neuroprotection: Heat Shock Proteins , 2002, Current medical research and opinion.

[15]  R. Kumar,et al.  The role of heat shock protein 70 in vitamin D receptor function. , 2001, Biochemical and biophysical research communications.

[16]  F. Diaz,et al.  Patterns of heat-shock protein 70 biosynthesis following human traumatic brain injury. , 1998, Journal of neurotrauma.

[17]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[18]  J. Langlois,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths , 2006 .